Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.040
+0.010 (0.97%)
At close: May 9, 2025, 4:00 PM
1.100
+0.060 (5.77%)
After-hours: May 9, 2025, 7:44 PM EDT
Fate Therapeutics Market Cap
Fate Therapeutics has a market cap or net worth of $119.19 million as of May 9, 2025. Its market cap has decreased by -73.54% in one year.
Market Cap
119.19M
Enterprise Value
-74.61M
1-Year Change
-73.54%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since October 1, 2013, Fate Therapeutics's market cap has decreased from $126.10M to $119.19M, a decrease of -5.48%. That is a compound annual growth rate of -0.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 118.00M | -37.20% |
| Dec 31, 2024 | 187.90M | -49.05% |
| Dec 29, 2023 | 368.80M | -62.38% |
| Dec 30, 2022 | 980.40M | -82.45% |
| Dec 31, 2021 | 5.59B | -29.57% |
| Dec 31, 2020 | 7.93B | 436.27% |
| Dec 31, 2019 | 1.48B | 78.70% |
| Dec 31, 2018 | 827.80M | 225.01% |
| Dec 29, 2017 | 254.70M | 197.20% |
| Dec 30, 2016 | 85.70M | -11.47% |
| Dec 31, 2015 | 96.80M | -6.47% |
| Dec 31, 2014 | 103.50M | -19.01% |
| Dec 31, 2013 | 127.80M | 1.35% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 676.89B |
| Johnson & Johnson | 374.39B |
| UnitedHealth Group | 347.24B |
| AbbVie | 333.89B |
| Novo Nordisk | 287.72B |
| Abbott Laboratories | 234.01B |
| Novartis AG | 215.89B |
| AstraZeneca | 208.98B |